SynthesisFrontiers in immunology2023

Immune-related adverse events associated with nab-paclitaxel/paclitaxel combined with immune checkpoint inhibitors: a systematic review and network meta-analysis.

Wenjing Hao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.